Differentiation of Primary Central Nervous System Lymphomas and Glioblastomas: Comparisons of Diagnostic Performance of Dynamic Susceptibility Contrast-Enhanced Perfusion MR Imaging without and with Contrast-Leakage Correction

C.H. Toh; K.-C. Wei; C.-N. Chang; S.-H. Ng; H.-F. Wong

doi:10.3174/ajnr.A3383

REFERENCES

1.↵
1. Haldorsen IS,
2. Espeland A,
3. Larsson EM
. Central nervous system lymphoma: characteristic findings on traditional and advanced imaging. AJNR Am J Neuroradiol 2011;32:984–92
Abstract/FREE Full Text
2.↵
1. Toh CH,
2. Castillo M,
3. Wong AM,
4. et al
. Primary cerebral lymphoma and glioblastoma multiforme: differences in diffusion characteristics evaluated with diffusion tensor imaging. AJNR Am J Neuroradiol 2008;29:471–75
Abstract/FREE Full Text
3.↵
1. Zaharchuk G
. Theoretical basis of hemodynamic MR imaging techniques to measure cerebral blood volume, cerebral blood flow, and permeability. AJNR Am J Neuroradiol 2007;28:1850–58
Abstract/FREE Full Text
4.↵
1. Cha S
. Update on brain tumor imaging: from anatomy to physiology. AJNR Am J Neuroradiol 2006;27:475–87
FREE Full Text
5.↵
1. Provenzale JM,
2. Mukundan S,
3. Barboriak DP
. Diffusion-weighted and perfusion MR imaging for brain tumor characterization and assessment of treatment response. Radiology 2006;239:632–49
CrossRef PubMed Web of Science
6.↵
1. Sugahara T,
2. Korogi Y,
3. Shigematsu Y,
4. et al
. Perfusion-sensitive MRI of cerebral lymphomas: a preliminary report. J Comput Assist Tomogr 1999;23:232–37
CrossRef PubMed
7.↵
1. Cho SK,
2. Na DG,
3. Ryoo JW,
4. et al
. Perfusion MR imaging: clinical utility for the differential diagnosis of various brain tumors. Korean J Radiol 2002;3:171–79
PubMed
8.↵
1. Hartmann M,
2. Heiland S,
3. Harting I,
4. et al
. Distinguishing of primary cerebral lymphoma from high-grade glioma with perfusion-weighted magnetic resonance imaging. Neurosci Lett 2003;338:119–22
CrossRef PubMed Web of Science
9.↵
1. Calli C,
2. Kitis O,
3. Yunten N,
4. et al
. Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors. Eur J Radiol 2006;58:394–403
CrossRef PubMed
10.↵
1. Liao W,
2. Liu Y,
3. Wang X,
4. et al
. Differentiation of primary central nervous system lymphoma and high-grade glioma with dynamic susceptibility contrast-enhanced perfusion magnetic resonance imaging. Acta Radiol 2009;50:217–25
Abstract/FREE Full Text
11.↵
1. Lee IH,
2. Kim ST,
3. Kim HJ,
4. et al
. Analysis of perfusion weighted image of CNS lymphoma. Eur J Radiol 2010;76:48–51
CrossRef PubMed
12.↵
1. Mangla R,
2. Kolar B,
3. Zhu T,
4. et al
. Percentage signal recovery derived from MR dynamic susceptibility contrast imaging is useful to differentiate common enhancing malignant lesions of the brain. AJNR Am J Neuroradiol 2011;32:1004–10
Abstract/FREE Full Text
13.↵
1. Wang S,
2. Kim S,
3. Chawla S,
4. et al
. Differentiation between glioblastomas, solitary brain metastases, and primary cerebral lymphomas using diffusion tensor and dynamic susceptibility contrast-enhanced MR imaging. AJNR Am J Neuroradiol 2011;32:507–14
Abstract/FREE Full Text
14.↵
1. Ma JH,
2. Kim HS,
3. Rim NJ,
4. et al
. Differentiation among glioblastoma multiforme, solitary metastatic tumor, and lymphoma using whole-tumor histogram analysis of the normalized cerebral blood volume in enhancing and perienhancing lesions. AJNR Am J Neuroradiol 2010;31:1699–706
Abstract/FREE Full Text
15.↵
1. Boxerman JL,
2. Schmainda KM,
3. Weisskoff RM
. Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. AJNR Am J Neuroradiol 2006;27:859–67
Abstract/FREE Full Text
16.↵
1. Server A,
2. Graff BA,
3. Orheim TE,
4. et al
. Measurements of diagnostic examination performance and correlation analysis using microvascular leakage, cerebral blood volume, and blood flow derived from 3T dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in glial tumor grading. Neuroradiology 2011;53:435–47
CrossRef PubMed Web of Science
17.↵
1. Molnár PP,
2. O'Neill BP,
3. Scheithauer BW,
4. et al
. The blood-brain barrier in primary CNS lymphomas: ultrastructural evidence of endothelial cell death. Neuro Oncol 1999;1:89–100
Abstract/FREE Full Text
18.↵
1. Warnke PC,
2. Timmer J,
3. Ostertag CB,
4. et al
. Capillary physiology and drug delivery in central nervous system lymphomas. Ann Neurol 2005;57:136–39
CrossRef PubMed
19.↵
1. Takeuchi H,
2. Matsuda K,
3. Kitai R,
4. et al
. Angiogenesis in primary central nervous system lymphoma (PCNSL). J Neurooncol 2007;84:141–45
CrossRef PubMed
20.↵
1. Schramm P,
2. Xyda A,
3. Klotz E,
4. et al
. Dynamic CT perfusion imaging of intra-axial brain tumours: differentiation of high-grade gliomas from primary CNS lymphomas. Eur Radiol 2010;20:2482–90
CrossRef PubMed
21.↵
1. Emblem KE,
2. Mouridsen K,
3. Borra RJ,
4. et al
. Does DSC-derived CA extravasation correlate with DCE K^trans? In: Procedures of the International Society of Magnetic Resonance in Medicine, Montreal, Quebec, Canada. May 6–13, 2011;1:791
22.↵
1. Sadeghi N,
2. D'Haene N,
3. Decaestecker C,
4. et al
. Apparent diffusion coefficient and cerebral blood volume in brain gliomas: relation to tumor cell density and tumor microvessel density based on stereotactic biopsies. AJNR Am J Neuroradiol 2008;29:476–82
Abstract/FREE Full Text
23.↵
1. Cha S,
2. Lupo JM,
3. Chen MH,
4. et al
. Differentiation of glioblastoma multiforme and single brain metastasis by peak height and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. AJNR Am J Neuroradiol 2007;28:1078–84
Abstract/FREE Full Text
24.↵
1. Boxerman JL,
2. Prah DE,
3. Paulson ES,
4. et al
. The role of preload and leakage correction in gadolinium-based cerebral blood volume estimation determined by comparison with MION as a criterion standard. AJNR Am J Neuroradiol 2012;33:1081–87
Abstract/FREE Full Text

In this issue

Download PDF

Email Article

Citation Tools

Purchase

Cited By...

More in this TOC Section

Show more BRAIN

[1] 1.↵
Haldorsen IS,
Espeland A,
Larsson EM
. Central nervous system lymphoma: characteristic findings on traditional and advanced imaging. AJNR Am J Neuroradiol 2011;32:984–92
Abstract/FREE Full Text

[2] Haldorsen IS,

[3] Espeland A,

[4] Larsson EM

[5] 2.↵
Toh CH,
Castillo M,
Wong AM,
et al
. Primary cerebral lymphoma and glioblastoma multiforme: differences in diffusion characteristics evaluated with diffusion tensor imaging. AJNR Am J Neuroradiol 2008;29:471–75
Abstract/FREE Full Text

[6] Toh CH,

[7] Castillo M,

[8] Wong AM,

[9] et al

[10] 3.↵
Zaharchuk G
. Theoretical basis of hemodynamic MR imaging techniques to measure cerebral blood volume, cerebral blood flow, and permeability. AJNR Am J Neuroradiol 2007;28:1850–58
Abstract/FREE Full Text

[11] Zaharchuk G

[12] 4.↵
Cha S
. Update on brain tumor imaging: from anatomy to physiology. AJNR Am J Neuroradiol 2006;27:475–87
FREE Full Text

[13] Cha S

[14] 5.↵
Provenzale JM,
Mukundan S,
Barboriak DP
. Diffusion-weighted and perfusion MR imaging for brain tumor characterization and assessment of treatment response. Radiology 2006;239:632–49
CrossRef PubMed Web of Science

[15] Provenzale JM,

[16] Mukundan S,

[17] Barboriak DP

[18] 6.↵
Sugahara T,
Korogi Y,
Shigematsu Y,
et al
. Perfusion-sensitive MRI of cerebral lymphomas: a preliminary report. J Comput Assist Tomogr 1999;23:232–37
CrossRef PubMed

[19] Sugahara T,

[20] Korogi Y,

[21] Shigematsu Y,

[22] et al

[23] 7.↵
Cho SK,
Na DG,
Ryoo JW,
et al
. Perfusion MR imaging: clinical utility for the differential diagnosis of various brain tumors. Korean J Radiol 2002;3:171–79
PubMed

[24] Cho SK,

[25] Na DG,

[26] Ryoo JW,

[27] et al

[28] 8.↵
Hartmann M,
Heiland S,
Harting I,
et al
. Distinguishing of primary cerebral lymphoma from high-grade glioma with perfusion-weighted magnetic resonance imaging. Neurosci Lett 2003;338:119–22
CrossRef PubMed Web of Science

[29] Hartmann M,

[30] Heiland S,

[31] Harting I,

[32] et al

[33] 9.↵
Calli C,
Kitis O,
Yunten N,
et al
. Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors. Eur J Radiol 2006;58:394–403
CrossRef PubMed

[34] Calli C,

[35] Kitis O,

[36] Yunten N,

[37] et al

[38] 10.↵
Liao W,
Liu Y,
Wang X,
et al
. Differentiation of primary central nervous system lymphoma and high-grade glioma with dynamic susceptibility contrast-enhanced perfusion magnetic resonance imaging. Acta Radiol 2009;50:217–25
Abstract/FREE Full Text

[39] Liao W,

[40] Liu Y,

[41] Wang X,

[42] et al

[43] 11.↵
Lee IH,
Kim ST,
Kim HJ,
et al
. Analysis of perfusion weighted image of CNS lymphoma. Eur J Radiol 2010;76:48–51
CrossRef PubMed

[44] Lee IH,

[45] Kim ST,

[46] Kim HJ,

[47] et al

[48] 12.↵
Mangla R,
Kolar B,
Zhu T,
et al
. Percentage signal recovery derived from MR dynamic susceptibility contrast imaging is useful to differentiate common enhancing malignant lesions of the brain. AJNR Am J Neuroradiol 2011;32:1004–10
Abstract/FREE Full Text

[49] Mangla R,

[50] Kolar B,

[51] Zhu T,

[52] et al

[53] 13.↵
Wang S,
Kim S,
Chawla S,
et al
. Differentiation between glioblastomas, solitary brain metastases, and primary cerebral lymphomas using diffusion tensor and dynamic susceptibility contrast-enhanced MR imaging. AJNR Am J Neuroradiol 2011;32:507–14
Abstract/FREE Full Text

[54] Wang S,

[55] Kim S,

[56] Chawla S,

[57] et al

[58] 14.↵
Ma JH,
Kim HS,
Rim NJ,
et al
. Differentiation among glioblastoma multiforme, solitary metastatic tumor, and lymphoma using whole-tumor histogram analysis of the normalized cerebral blood volume in enhancing and perienhancing lesions. AJNR Am J Neuroradiol 2010;31:1699–706
Abstract/FREE Full Text

[59] Ma JH,

[60] Kim HS,

[61] Rim NJ,

[62] et al

[63] 15.↵
Boxerman JL,
Schmainda KM,
Weisskoff RM
. Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. AJNR Am J Neuroradiol 2006;27:859–67
Abstract/FREE Full Text

[64] Boxerman JL,

[65] Schmainda KM,

[66] Weisskoff RM

[67] 16.↵
Server A,
Graff BA,
Orheim TE,
et al
. Measurements of diagnostic examination performance and correlation analysis using microvascular leakage, cerebral blood volume, and blood flow derived from 3T dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in glial tumor grading. Neuroradiology 2011;53:435–47
CrossRef PubMed Web of Science

[68] Server A,

[69] Graff BA,

[70] Orheim TE,

[71] et al

[72] 17.↵
Molnár PP,
O'Neill BP,
Scheithauer BW,
et al
. The blood-brain barrier in primary CNS lymphomas: ultrastructural evidence of endothelial cell death. Neuro Oncol 1999;1:89–100
Abstract/FREE Full Text

[73] Molnár PP,

[74] O'Neill BP,

[75] Scheithauer BW,

[76] et al

[77] 18.↵
Warnke PC,
Timmer J,
Ostertag CB,
et al
. Capillary physiology and drug delivery in central nervous system lymphomas. Ann Neurol 2005;57:136–39
CrossRef PubMed

[78] Warnke PC,

[79] Timmer J,

[80] Ostertag CB,

[81] et al

[82] 19.↵
Takeuchi H,
Matsuda K,
Kitai R,
et al
. Angiogenesis in primary central nervous system lymphoma (PCNSL). J Neurooncol 2007;84:141–45
CrossRef PubMed

[83] Takeuchi H,

[84] Matsuda K,

[85] Kitai R,

[86] et al

[87] 20.↵
Schramm P,
Xyda A,
Klotz E,
et al
. Dynamic CT perfusion imaging of intra-axial brain tumours: differentiation of high-grade gliomas from primary CNS lymphomas. Eur Radiol 2010;20:2482–90
CrossRef PubMed

[88] Schramm P,

[89] Xyda A,

[90] Klotz E,

[91] et al

[92] 21.↵
Emblem KE,
Mouridsen K,
Borra RJ,
et al
. Does DSC-derived CA extravasation correlate with DCE K^trans? In: Procedures of the International Society of Magnetic Resonance in Medicine, Montreal, Quebec, Canada. May 6–13, 2011;1:791

[93] Emblem KE,

[94] Mouridsen K,

[95] Borra RJ,

[96] et al

[97] 22.↵
Sadeghi N,
D'Haene N,
Decaestecker C,
et al
. Apparent diffusion coefficient and cerebral blood volume in brain gliomas: relation to tumor cell density and tumor microvessel density based on stereotactic biopsies. AJNR Am J Neuroradiol 2008;29:476–82
Abstract/FREE Full Text

[98] Sadeghi N,

[99] D'Haene N,

[100] Decaestecker C,

[101] et al

[102] 23.↵
Cha S,
Lupo JM,
Chen MH,
et al
. Differentiation of glioblastoma multiforme and single brain metastasis by peak height and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. AJNR Am J Neuroradiol 2007;28:1078–84
Abstract/FREE Full Text

[103] Cha S,

[104] Lupo JM,

[105] Chen MH,

[106] et al

[107] 24.↵
Boxerman JL,
Prah DE,
Paulson ES,
et al
. The role of preload and leakage correction in gadolinium-based cerebral blood volume estimation determined by comparison with MION as a criterion standard. AJNR Am J Neuroradiol 2012;33:1081–87
Abstract/FREE Full Text

[108] Boxerman JL,

[109] Prah DE,

[110] Paulson ES,

[111] et al

Main menu

User menu

Search

American Journal of Neuroradiology

Differentiation of Primary Central Nervous System Lymphomas and Glioblastomas: Comparisons of Diagnostic Performance of Dynamic Susceptibility Contrast-Enhanced Perfusion MR Imaging without and with Contrast-Leakage Correction

REFERENCES

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

News and Updates

Resources

Opportunities

American Society of Neuroradiology

Main menu

User menu

Search

Differentiation of Primary Central Nervous System Lymphomas and Glioblastomas: Comparisons of Diagnostic Performance of Dynamic Susceptibility Contrast-Enhanced Perfusion MR Imaging without and with Contrast-Leakage Correction

REFERENCES

In this issue

Citation Manager Formats

Jump to section

Related Articles

Cited By...

More in this TOC Section

Similar Articles

News and Updates

Resources

Opportunities

American Society of Neuroradiology